Sabashini K Ramchand

Loading... 2 0 20 0 false
Credit Name
Sabashini K Ramchand
Full Name
Ramchand, Sabashini K
 
 
Loading... 3 0 20 0 false

Publications

Results 1-20 of 20 (Search time: 0.005 seconds).

Publication YearTitleAuthor(s)
15-Jan-2024Cardiometabolic Effects of Denosumab in Premenopausal Women with Breast Cancer Receiving Estradiol Suppression: RCT.Ramchand, Sabashini K ; Hoermann, Rudolf; White, Shane ; Yeo, Belinda ; Francis, Prudence A; Xu, Cecilia L H; Zajac, Jeffrey D ; Seeman, Ego ; Grossmann, Mathis 
2Jan-2024Primary hyperparathyroidism in adults-(Part I) assessment and medical management: Position statement of the endocrine society of Australia, the Australian & New Zealand endocrine surgeons, and the Australian & New Zealand bone and mineral society.Milat, Frances; Ramchand, Sabashini K ; Herath, Madhuni; Gundara, Justin; Harper, Simon; Farrell, Stephen G ; Girgis, Christian M; Clifton-Bligh, Roderick; Schneider, Hans G; De Sousa, Sunita M C; Gill, Anthony J; Serpell, Jonathan; Taubman, Kim; Christie, James; Carroll, Richard W; Miller, Julie A; Grossmann, Mathis 
318-Jul-2023Protocol: Can coronary artery calcium score identified on thoracic planning CT scans be used and actioned to identify cancer survivors at high risk of cardiac events: A feasibility study in cancer survivors undergoing radiotherapy in Australia.Dalla Via, Jack; Stewart, Nina; Kennedy, Mary A; Cehic, Daniel A; Purnell, Peter; Toohey, Joanne; Morton, Jamie; Ramchand, Sabashini K ; Lewis, Joshua R; Zissiadis, Yvonne
4Jan-2023The Effect of Zoledronic Acid on Bone Microarchitecture and Strength after Denosumab and Teriparatide Administration: DATA-HD Study Extension.Ramchand, Sabashini K ; David, Natalie L; Lee, Hang; Bruce, Michael; Bouxsein, Mary L; Tsai, Joy N; Leder, Benjamin Z
519-Dec-2021Primary hyperparathyroidism in adults-(Part II) surgical management and postoperative follow-up: Position statement of the Endocrine Society of Australia, The Australian & New Zealand Endocrine Surgeons, and The Australian & New Zealand Bone and Mineral Society.Miller, Julie A; Gundara, Justin; Harper, Simon; Herath, Madhuni; Ramchand, Sabashini K ; Farrell, Stephen G ; Serpell, Jonathan; Taubman, Kim; Christie, James; Girgis, Christian M; Schneider, Hans G; Clifton-Bligh, Roderick; Gill, Anthony J; De Sousa, Sunita M C; Carroll, Richard W; Milat, Frances; Grossmann, Mathis 
6May-2021Efficacy of Zoledronic Acid in Maintaining Areal and Volumetric Bone Density after Combined Denosumab and Teriparatide Administration: DATA-HD Study Extension.Ramchand, Sabashini K ; David, Natalie L; Lee, Hang; Eastell, Richard; Tsai, Joy N; Leder, Benjamin Z
7Jan-2021Effects of Combination Denosumab and High-Dose Teriparatide Administration on Bone Microarchitecture and Estimated Strength: the DATA-HD HR-pQCT Study.Ramchand, Sabashini K ; David, Natalie L; Lee, Hang; Bruce, Michael; Bouxsein, Mary L; Leder, Benjamin Z; Tsai, Joy N
831-Mar-2020Reduced Bone Modeling and Unbalanced Bone Remodeling: Targets for Antiresorptive and Anabolic Therapy.Ramchand, Sabashini K ; Seeman, Ego 
9Mar-2020Bone mineral density response with denosumab in combination with standard or high-dose teriparatide: the DATA-HD RCT.Ramchand, Sabashini K ; David, Natalie L; Leder, Benjamin Z; Tsai, Joy N
10Sep-2019Assessment and management of bone health in women with oestrogen receptor-positive breast cancer receiving endocrine therapy: position statement summary.Grossmann, Mathis ; Ramchand, Sabashini K ; Milat, Frances; Vincent, Amanda; Lim, Elgene; Kotowicz, Mark A; Hicks, Jill; Teede, Helena J
111-Jul-2019Cardiometabolic Effects of Endocrine Treatment of Estrogen Receptor-Positive Early Breast Cancer.Cheung, Yee-Ming Melody ; Ramchand, Sabashini K ; Yeo, Belinda ; Grossmann, Mathis 
1221-Mar-2019Bone health in women with breast cancer.Ramchand, Sabashini K ; Cheung, Y M; Grossmann, Mathis 
132019The effects of adjuvant endocrine therapy on bone health in women with breast cancer.Ramchand, Sabashini K ; Cheung, Yee-Ming Melody ; Yeo, Belinda ; Grossmann, Mathis 
146-Sep-2018Advances and Unmet Needs in the Therapeutics of Bone Fragility.Ramchand, Sabashini K ; Seeman, Ego 
15Jul-2018Pitfalls in bone density monitoring in prostate cancer during anti-resorptive treatment.Cheung, Yee-Ming Melody ; Ramchand, Sabashini K ; Grossmann, Mathis 
169-May-2018Assessment and management of bone health in women with oestrogen receptor-positive breast cancer receiving endocrine therapy: Position statement of the Endocrine Society of Australia, the Australian and New Zealand Bone & Mineral Society, the Australasian Menopause Society and the Clinical Oncology Society of Australia.Grossmann, Mathis ; Ramchand, Sabashini K ; Milat, Frances; Vincent, Amanda; Lim, Elgene; Kotowicz, Mark A; Hicks, Jill; Teede, Helena
172018The Influence of Cortical Porosity on the Strength of Bone During Growth and Advancing Age.Ramchand, Sabashini K ; Seeman, Ego 
18Oct-2017Premenopausal women with early breast cancer treated with estradiol suppression have severely deteriorated bone microstructure.Ramchand, Sabashini K ; Seeman, Ego ; Wang, Xiao-Fang ; Ghasem-Zadeh, Ali ; Francis, Prudence A; Ponnusamy, Evangeline J; Bardin, Michele S; Bui, Minh; Zebaze, Roger; Zajac, Jeffrey D ; Grossmann, Mathis 
19Sep-2017Higher maternal serum prolactin levels are associated with reduced glucose tolerance during pregnancyEkinci, Elif I ; Torkamani, Niloufar ; Ramchand, Sabashini K ; Churilov, Leonid ; Sikaris, Ken A; Lu, Zhong X; Houlihan, Christine A 
20Nov-2016Adjuvant endocrine therapy in women with oestrogen-receptor-positive breast cancer: How should the skeletal and vascular side effects be assessed and managed?Ramchand, Sabashini K ; Lim, Elgene; Grossmann, Mathis